Sergio de Jesus Romero Tapia

Dr. Sergio de Jesus Romero Tapia


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
VGVictor Gonzalez-Uribe
Victor Gonzalez-Uribe
STSergio de Jesus Romero Tapia
Sergio de Jesus Romero Tapia
CRCarlos E. Rodriguez-Martinez
Carlos E. Rodriguez-Martinez
Asthma is a widespread disease affecting approximately 300-million people globally. This condition leads to significant morbidity, mortality, and economic strain worldwide. Recent clinical and laboratory research advancements have illuminated the immunological factors contributing to asthma. As of now, asthma is understood to be a heterogeneous disease. Personalized medicine involves categorizing asthma by its endotypes, linking observable characteristics to specific immunological mechanisms. Identifying these endotypic mechanisms is paramount in accurately profiling patients and tailoring therapeutic approaches using innovative biological agents targeting distinct immune pathways. This article presents a synopsis of the key immunological mechanisms implicated in the pathogenesis and manifestation of the disease’s phenotypic traits and individualized treatments for severe asthma subtypes.

1 March 2015 in Allergologia et Immunopathologia
Verified
Journal Article
Closed access
STSergio de Jesus Romero Tapia
Sergio de Jesus Romero Tapia
HCH.H. Cámara-Combaluzier
H.H. Cámara-Combaluzier
MBM.A. Baeza-Bacab
M.A. Baeza-Bacab
RCR. Cerino-Javier
R. Cerino-Javier
DBD.P. Bulnes-Mendizabal
D.P. Bulnes-Mendizabal
CVC. Virgen-Ortega
C. Virgen-Ortega

24 July 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
VGVictor Gonzalez-Uribe
Victor Gonzalez-Uribe
STSergio de Jesus Romero Tapia
Sergio de Jesus Romero Tapia
CRCarlos E. Rodriguez-Martinez
Carlos E. Rodriguez-Martinez
Asthma is a prevalent disease that around 300 million worldwide, resulting in substantial morbidity, mortality, and economic burden on a global scale. New clinical and laboratory research has shed light on the immunology causing asthma. Asthma is now recognized as a heterogeneous disease. A personalized medicine is based on the classification of asthma by endotype by linking observable characteristics to immunological mechanisms. Identifying endotype mechanisms is essential for better characterizing patients and personalizing therapeutic approaches with novel biological agents that target specific immune pathways. This article provides a summary of the major immunological mechanisms involved in the pathogenesis and emergence of the disease's phenotypic features, as well as the individualized treatment for severe asthma subtypes